Biotech Health and Life Products Company Profile

Similar documents
Science, Technology & Innovation Indicators

Executive Summary World Robotics 2018 Industrial Robots

Jørgen Mads Clausen. Europe North America Latin America Asia-Pacific. Danfoss

Gender Equality Commitment Workshop JUNE 2018

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Corporate Mind 2013 Corporate Responsibility Report

Heinrich Jessen, Chairman, Jebsen & Jessen (SEA)

Corporate Mind 2015 Corporate Responsibility Report

Corporate Mind 2016 Corporate Responsibility Report

NPES understands the intricate dynamics involved in

Fasson > The First Fifty Years

Firm Foundation, Forward Focus

Strategic Plan Approved by Council 7 June 2010

Welcome to RHI Magnesita The driving force of the refractory industry

Canadian Health Food Association. Pre-budget consultations in advance of the 2018 budget

TAB V. VISION 2030: Distinction, Access and Excellence

Interview with Prof. Dr. Stefan Mecheels, CEO Hohenstein Institute in Bönnigheim (Germany)

2010 IRI Annual Meeting R&D in Transition

Welcome to the IFR Press Conference 30 August 2012, Taipei

Turkey Women Matter 2016 Turkey's Potential: Place of Women in the Business World

Rocco E. Testani, Partner

Georges Bougaud. Europe North America Latin America Asia-Pacific. Recamier

Higher School of Economics, Vienna

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

Noble Corporation. Don Jacobsen Senior Vice President Industry & Government Relations Marine/Offshore Industry Conference 29 March 2012

SEMICONDUCTOR INDUSTRY ASSOCIATION FACTBOOK

Interaction Concept: Transformative Transactions: Designing for New Banking Experiences

Research Guidance. GE Global Research. Design for Breakthrough Research In an Academic Settings GCEP. November 11, 2005

Vision. We strive to be an accomplished business player in the region assuring superior value to all stakeholders.

Presentation. March 2007

2019 Sponsorship Opportunities

GENDER PAY GAP REPORT

Guido Vanherpe. Europe North America Latin America Asia-Pacific. La Lorraine Bakery Group

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Construction Market in Europe: A Supplier s Point of View

WE CARE is not only our promise, but also the basic philosophy that drives all of our personal care activities. Our changing world constantly demands

Transition PPT Template. J.P. Morgan. June 2015 V 3.0. Energy Equity Conference June 27, 2017

[Overview of the Consolidated Financial Results]

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter

WRITTEN SUBMISSION OF GE CAPITAL TO THE FINANCIAL CRISIS INQUIRY COMMISSION

Chemistry Based on. Toray Profile: Overview and Philosophy

Report on Global Sneaker Market by Player, Region, Type, Application and Sales Channel.pdf

PHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.

Case Studies Effective Use of IP Assets by SMEs in their Business Strategy

(3) How does one obtain patent protection?

Poultry Science Association PSA. Advancing the poultry sciences since 1908

NEWS RELEASE. Life sciences companies tout their expertise in India

Innovation Economy. Creating the. Dr. G. Wayne Clough President, Georgia Institute of Technology

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

STEMEDICA EXPANDS GLOBALLY WITH INTERNATIONAL HEADQUARTERS IN SWITZERLAND

Losing our National Competitiveness is Not an Option

Comfort Ibrahim, Rice Processing. Executive Summary. October Business Description. Kingdom Impact. Investment Required. Name: Comfort Ibrahim

Corporate Social Responsibility: Historical Perspective

BIC 2022 Invent the Future

Managing a winning portfolio Bernard Hours

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

WORKING TODAY FOR A BETTER TOMORROW. What we do

BIXI MONTRÉAL CELEBRATES ITS TENTH ANNIVERSARY BY REVEALING SEVERAL NEW FEATURES AND STARTING THE SEASON FIVE DAYS EARLY

AC*. Alliance For Capital Access

700MHz awards and approaches in the region

Life Sciences Outlook. New York City 2016

Vorwerk Thermomix C O N S U L T A N C Y C A S E S T U D Y

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

CREATING MARKETS FOR MANUFACTURING DUSSELDORF, GERMANY IFC GLOBAL MANUFACTURING CONFERENCE

José Luis Calvo. Europe North America Latin America Asia-Pacific. Grupo Calvo

Investing in Regional Sustainability Norris Lozano, PDC

PCT Yearly Review 2017 Executive Summary. The International Patent System

The GenNx360 Trapped Asset Play Two Bites of the Apple to Create Value

Strategic Plan

Contents. 4. History 9. Introduction Vision and Corporate Principles Gestamp Innovation and Technology

Create for the future

T H O M S O N S C I E N T I F I C. World IP Today

INTERPERSONAL EFFECTIVENESS STUDY

Corporate presentation

THE HISTORY OF MSPA. Authors: Mike Bare, Mark Michelson, Veronica Karlsson, Aftab Anwar and Cristiani Oliveira

Selected Women s Organizations in Latin America and Asia-Pacific Countries

PEY Report. Lee Holmes. E-Commerce Technical Specialist, GE Global Exchange Services

FDM Asia-Pacific & Australia Graduate Programme

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

UCT Coatings, Inc. Fiscal Year 2014 Annual Financial Report And Shareholder Letter

John C. Hampton

CRAWFORD & COMPANY Annual Meeting of Shareholders

Metros at the Vanguard of Exports and Trade: Delivering the Next U.S. Economy

GORDON J. CAMPBELL 3 Peter Cooper Road, #12 C New York, New York

Overview of USP s Research and Innovation Activities. Michael Ambrose Ph.D. Director, Research and Innovation

August 17, The Testimony of Christopher P. Molineaux President & CEO Pennsylvania Bio

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

ENTERPRISE HOLDINGS INC. S ENTRY INTO CUBA PETE SMITH, VICE PRESIDENT OF GLOBAL FRANCHISING BRIAN S. GARCIA, DIRECTOR OF GLOBAL FRANCHISE SUPPORT

Digital Excellence Study

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

POST-SHOW REPORT GLOBAL PETROLEUM SHOW GLOBALPETROLEUMSHOW.COM JUNE 12-14, 2018 CALGARY, CANADA NORTH AMERICA S LEADING ENERGY EVENT

Digital Government and Digital Public Services

Cultivating Entrepreneurial Spirit in Asia

PANEL DISCUSSION & ROUNDTABLES

Leading the way through. Innovation. Dr. G. Wayne Clough President, Georgia Institute of Technology. GE Energy Sales Executives January 28, 2005

Globalization, Sustainability and Innovation

261 Gorham Road South Portland, ME Company Profile

This is an oral history interview conducted on May. 16th of 2003, conducted in Armonk, New York, with Uchinaga-san

MORRISON BRIDGEHEAD PROJECT Featuring the James Beard Public Market

Standard Chartered tackles avoidable blindness with charity football

Transcription:

Biotech Health and Life Products Company Profile Welcome to Biotech! The assessment projects for this class will examine different facets of the leadership of Biotech Health and Life Products, Inc. You will be exploring leadership within Biotech with the driving question of what skills does a Biotech leader need to lead the company now and in the future? History Wilford Barney was a young apprentice working for Peter Ulan, owner of a small apothecary shop in Yonkers, New York. During his apprenticeship, Barney created a general energy elixir that was based on a home remedy of his mother s back in Ireland. The elixir was produced specifically for many of Ulan s special customers. Made of all natural ingredients the elixir provided B12 and other vitamins to promote a healthy immune system. The energy boost was noticeable after only a week s use. The reputation of the elixir grew. In 1922, Barney took over Ulan s apothecary shop renaming the business, Barney s Apothecary. At that time, Barney decided to bottle his elixir and sell the formula to everyone rather than selected customers. Barney also gave bottles of the elixir to local peddlers who sold the product along with their wares receiving a commission on each bottle they sold. By 1929, the product was well known in Yonkers. Encouraged by the success in Yonkers Barney decided to branch out to New York City. In 1932, Barney built a small manufacturing plant near the store where he mixed and bottled the elixir for sale. By 1934, Barney expanded sales by putting the elixir in a quarter of the apothecary shops in New York City. Sales were booming and customers inquired about other products that Barney s had. In 1936, Barney started a new product called Night Relief, another of his mother s recipes. This product offered relief from night sweats and anxiety caused by menopausal symptoms or nerves. When this product proved a secret success with the ladies, Barney decided to bring his mother, Irene, from Ireland, and put her to work making new natural products. With his mother s help, Barney grew the business into a small but successful manufacturer of natural life products. Barney coined life products because the products tracked natural life events in the human body and attempted to improve the customer s discomfort in dealing with them. The name of the company was changed to Barney s Elixir and Life Products. The business continued to grow and with his mother s death in 1938 the company had a gross revenue of $178,000 a year. The depression took a toll on company profits but people

still needed the boosts to their health and were able to afford Barney s products as opposed to the medicine offered by doctors and hospitals. During World War II the company supplied the troops with a natural caffeine (Stay Clear) product that would keep soldiers awake for long periods of time and heighten their mental alertness. Government contracts derived from Stay Clear boosted the revenue of the company considerably and ushered in a new wave of interest of natural products. By 1950 Barney turned over the reins of the daily operations of the business to his children but remained on the Board of his family owned company. By this time, the company had expanded its manufacturing plants and sales nationally to include Detroit, Michigan, Los Lunas, New Mexico, Chicago, Illinois and Atlanta, Georgia. The revenue of the company was now close to 2.5 million dollars. In the 1960 s the social climate in America had changed and pharmaceutical companies took on greater importance in the treatment of people s health. The discovery of new drugs and better health care shifted the confidence in the American perspective away from natural products to traditional western medicine. Although the counter culture of America still supported natural supplements, popularity for Barney s products waned. In 1965, Wilford s granddaughter, Geraldine, took over the Research and Development Department (R&D) after receiving a degree in chemistry from Harvard. She had been trained as a child by her grandmother, Wilford s mother, and knew how the recipes should look. However, she had new ideas and with the approach of the 1970 s, was ready to join the Anjolie perfume commercial lifestyle depiction of a 70 s women that they could bring home the bacon and fry it up too. Due to the downturn in sales by 1970, the company turned to other countries for its sales base. Starting in Germany and other European countries where natural products are highly credible, Barney began to license the sale of the company s products to local manufacturers. The name recognition grew and by the 1980 s the company was grossing over 4 million dollars in gross sales. The company moved to overseas operations and manufactured in Germany. Wilford Barney died in 1981 shortly after seeing his first grandchild, Maximillian Barney, take over the President s positon of the company. Studying the trends in the 1990 s about the resurgence of natural health products Max as he liked to be called, decided it was time for Barney s to focus on the new interest in homeopathic and natural products especially at home in America where sales were static. In 1996, Max, wanting to get a sleeker and more modern feel to the company s products changed the company name and logo. No longer was Barney s a mom and pop operation but now were part of the Biotech nutraceutical market. Barney s Elixir and Life Products was now Biotech Health and Life Products. While the products would continue to show the old Barney logo, for name recognition the new logo would take prominence on the packaging. By 2000 the company was grossing about 1.1 billion in sales with an increase in market share. By 2012, Biotech had a 20% market share of the supplement business with

approximately $20 billion of sales. The growing interest in the bio-nutraceutical marketplace was catching the attention of the big pharmaceutical companies. Glaxo, Merke and Dupont began a massive shift to the new biotech business products. Currently sales for the company are at $35 billion. Maximillian Barney is still President and CEO. The stock is still held by the family and all senior management positions are held by family members. Current Company Vision: To help provide everyone with the healthiest life possible in the most natural of ways. Current Mission: To develop products that are safe, effective, affordable and natural with the customer s health always a primary goal. Current Fact Sheet Headquarters Yonkers, New York Worldwide web address www.biotechlife.com President Maximillian Barney 2016 Gross Sales US$ 35 billion Employees 35,000 in 6 countries worldwide Manufacturer Operations United States Europe Asia Pacific Latin America and Caribbean Canada Detroit, Michigan, Los Lunas, New Mexico, Chicago, Illinois and Atlanta, Georgia Wittllch, Germany, Baltimore, Ireland Melbourne, Australia Sao Paulo, Brazil Alberta, Canada Product Lines Major Competitors Protein and Fitness; Personal Care, Nutraceuticals, Vitamins and Food Supplements Protein and Fitness-GNC, Personal Care- Nestle Skin Care- Galderma, SA; Glaxo, Merke, General Mills. Vitamins and Food Supplements- GNC, Natures Plus, Natrol, Nature s Way, Nature s Bounty, Hain Celestial Group, Inc, Schiff Nutrition International, Nestle, General Mills, Now Foods and New Chapter Current Business Philosophy

Biotech has determined its long-term goal planning pattern should be no longer than 3 years. Three years seems more flexible than the seven year planning pattern previously used as change in the business climate is making it imperative to be more flexible. The need for innovation and competitive advantage ideas are the main focus for the next two years along with the company s commitment to becoming a triple bottom line company. Sustainability both for profit and planet is foremost in the minds of the leadership. The development of a triple bottom line company is in the best interest of the company because of the need to keep a strong natural product image link to the community and the desire for the company to be socially responsible. Protection of the suppliers and control over product quality is critical to the development of a sound life product. Current Growth Plans Business and Sales Biotech is looking to expand to Saudi Arabia in the next year. Currently products sold through European division but demand is great in the Arab countries. Although the company would like to sell in Israel as well, Arab countries are seen as a more lucrative expansion opportunity. Expansion of the production capacity in Sao Paulo is being considered as company can no longer keep up with sales projections. Product Development Biotech is looking to develop its cosmetic and food lines. Currently have lip balms but seeks to make a line of lipsticks, foundation, powder, eye makeup and cleaners from natural ingredients. Development of natural flavorings and whey products are under consideration. Current Eco Sustainability Commitments Currently, Biotech has commitments to build housing for several communities in Brazil and India where natural pharmaceutical ingredients are produced. The program reflects the company s strong commitment to become a triple bottom line company by the year 2021. Innovation and Adaptability Development of organizational structure and culture changes are being made to introduce more collaborative decision making as well as bringing the divisions closer together in the area of shared resources and communication. Emphasis is to encourage the exchange of ideas, create an environment that fosters new ideas and makes change easier in implementation. Biotech is concerned that the stateside organization is driving the overseas divisions and that new ideas are being encouraged because of the cultural differences in staff. Customer innovation workshops ran by the various divisions have highlighted that R&D in Europe and Australia are differences in customer preferences from US customer preferences. It is believed that US controlled resources are ignoring

these product preferences and are thus impeding sales overseas. Corporate leaders are examining the matter in an attempt to answer this cultural gap. Current Corporate Culture Barney s new image of a sleek, less clan-like organization has resulted in a family that is less than cohesive. Still, the family leaders are committed to maintaining the businesses cultural heritage because of the sense of unity and belonging, and to provide employees with a better understanding of the previous generations and to show how far the company has come. It is believed that the cultural heritage of the business demonstrates support for collaborative decision making something the company has successfully promoted throughout the organization. The family sees its employees as being customers and therefore encourages a customer-centric culture. Employees are encouraged to look at their work through the perspective of the customer and to make decisions using the customer s viewpoint. Currently there is a company-wide accountability to the customers and the entire workforce is expected to provide an extraordinary customer experience in every product made. Current Organizational Structure The company has a geographical division structure. However, within each division is a functional structure with production and sales at the hub. R&D, HR, IT and Finance have small staff in each division whose primary job is to liaise with headquarters to implement the decisions made. President and CEO Maximillian Barney Housed in headquarters is the R&D, HR, IT, and Finance Divisions South America Division North American Division European Division Executive Directive Asia Division Giles Hartford